⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Parvaneh BahmaniM.D.

Nephrology · Los Angeles, CA 90048

NPI: 1609887678

Share:

36

🟠 Elevated

Risk Flags

Extreme cost outlier (population + peer)High long-acting opioid rate vs peersHigh antipsychotic prescribing (65+)High fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

6,539

Total Claims

$6.1M

Drug Cost

241

Beneficiaries

$25K

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Cost per patient outlier+10
Elderly antipsychotic prescribing+10
Long-acting opioid rate+8
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 8,961 Nephrology providers

+1878%

Cost per patient vs peers

$25K vs $1,283 avg

+190%

Brand preference vs peers

26.0% vs 9.0% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

💰

Cost per patient is 1878% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

2.6%

Opioid Rate

170

Opioid Claims

$30K

Opioid Cost

10.6%

Long-Acting Rate

Brand vs Generic

74% generic

Brand: 1,680 claims · $5.8M

Generic: 4,787 claims · $268K

Patient Profile

72

Avg Age

47%

Female

2.24

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About